Impact of B.1.617 and RBD SARS-CoV-2 variants on vaccine efficacy: An in-silico approach

PURPOSE: The existing panels of COVID-19 vaccines are based on the spike protein of an earlier SARS-CoV-2 strain that emerged in Wuhan, China. However, the evolving nature of SARS-CoV-2 has resulted in the emergence of new variants, thereby posing a greater challenge in the management of the disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranjan, Prashant, Neha, Devi, Chandra, Jain, Garima, Mallick, Chandana Basu, Das, Parimal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Indian Association of Medical Microbiologists. Published by Elsevier B.V. 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971047/
https://www.ncbi.nlm.nih.gov/pubmed/35370005
http://dx.doi.org/10.1016/j.ijmmb.2022.03.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971047/
https://www.ncbi.nlm.nih.gov/pubmed/35370005
http://dx.doi.org/10.1016/j.ijmmb.2022.03.009

Ejemplares similares